Private Label Iontophoresis Electrode

Private Label Iontophoresis Electrode
Details:
Materials: Constructed using a medical-grade foam or non-woven cloth backing, an Ag/AgCl conductive layer on a PET substrate, and a non-reactive synthetic fiber reservoir.

Standards: Manufacturing audited under ISO 13485. Biocompatibility compliance per ISO 10993 (Cytotoxicity, Sensitization).

Principle: These electrodes utilize the Ag/AgCl redox reaction to prevent the electrolysis of water at the skin interface. This maintains a steady electrical potential, ensuring the drug’s ionic mobility remains constant throughout the session.

MOQ: 5,000 sets for standard clinical configurations; 10,000+ for custom reservoir tooling.
Send Inquiry
Download
Description
Technical Parameters
 

Private Label Iontophoresis Electrodes | Ag/AgCl OEM | TOP-RANK

 

 

Technical manufacturing of iontophoretic electrodes for transdermal drug delivery. Features Ag/AgCl redox stability and pH-buffered reservoirs to prevent chemical burns during DC therapy.

 

Product Overview

 

These are active transdermal components designed for private label integration into iontophoretic drug delivery systems. Unlike AC-based TENS pads, these utilize a Silver/Silver-Chloride (Ag/AgCl) interface to manage constant Direct Current (DC). We provide these as white-label components for pharmaceutical R&D and clinical brands requiring a stable ionic bridge for localized medication delivery.

 

Key Features

 

Chemical Burn Prevention (pH Buffering)

Constant DC therapy generates hydroxyl ions (OH-) at the cathode, leading to NaOH buildup. If the interface is not buffered, it results in high-pH chemical burns. We integrate a proprietary pH-balancing layer within the fiber reservoir to lock the skin-contact pH between 4.5 and 6.5 for the duration of the 20-40 minute delivery cycle.

 

Ag/AgCl Redox Stability

Carbon-only electrodes polarize under DC, causing a rapid spike in resistance and an immediate drop in drug delivery rate. By controlling the Silver-to-Silver-Chloride ratio, we ensure the impedance stays flat. This is critical for pharmaceutical protocols requiring a linear dosage curve.

 

Peripheral Fluid Isolation

Leakage of the drug solution to the adhesive border creates a low-resistance "short circuit" at the patch edge. Our private label pads use a high-density isolation ring to contain the medication within the reservoir, preventing edge-effect burns and ensuring 100% current density through the drug-saturated zone.

Applications

 

 

  • Dermatology: Hyperhidrosis treatment (anticholinergics) and needle-free anesthesia (Lidocaine).
  • Orthopedics: Active delivery of Dexamethasone Sodium Phosphate for localized inflammation.
  • Aesthetic Medicine: Iontophoretic delivery of ionized serums and collagen precursors.

 

OEM & Private Label

 

We operate specialized production nodes in China and Vietnam to provide supply chain redundancy and logistics flexibility for global B2B clients.

  • Custom Die-Cutting: Electrodes can be shaped to fit specific anatomical sites (e.g., joints, face, or underarms).
  • Branding: Private label printing on the backing material and the multi-layer foil pouch.
  • Reservoir Tuning: Modification of the fiber matrix to accommodate different drug viscosities and polarities.

 

Certifications

 

 

  • Regulatory: FDA 510(k), CE (MDR), and UKCA.
  • Systems: ISO 13485 and MDSAP.
  • QC Protocols: Every production batch is tested for pH drift under a 4.0mA DC load and Ag/AgCl coating thickness (measured in microns) to ensure performance consistency across all lots.

 

FAQ

Q: Can these electrodes be reused for the same patient?

A: No. After one session, the Ag/AgCl layer is partially depleted and the pH buffer is consumed. Re-using the patch will result in non-linear drug delivery and an increased risk of pH-induced skin damage.

Q: How do you prevent drug-material interaction?

A: We use inert fiber matrices that do not bind to the ionized drug molecules. For new pharmaceutical compounds, we recommend compatibility testing to ensure the drug's potency is not compromised by the electrode substrate.

CTA

 

B2B project managers can request pH-drift stability reports and Ag/AgCl impedance data for regulatory filing support.

👉 [Request Technical Data Sheets]

 

Hot Tags: private label iontophoresis electrode, China private label iontophoresis electrode manufacturers, suppliers, factory, Iontophoresis Patches, dexamethasone for iontophoresis patch, iomed patch, Iontophoresis Pad, iontophoresis cortisone patch, ionto pads

 

Serial Number

Product Model

Product Appearance

Fill Volume

Maximum current

/maximum dose

Electrode types

01

ION-T01

Iontophoresis Pad factory

1.5 cc

4.0 mA / 80mA-min

Active drug delivery electrode

02

ION-T02

Iontophoresis electrode supplier

2.5 cc

4.0 mA / 80mA-min

Active drug delivery electrode

03

ION-T03

iontophoresis electrode

4.0 cc

4.0 mA / 80mA-min

Active drug delivery electrode

04

ION-T04

Iontophoresis patches supplier

2.0 cc

4.0 mA / 80mA-min

Active drug delivery electrode

05

ION-T05

image005

/

/

Return electrode

Send Inquiry